The Art of the Technical Pivot: How Hardware Giants Dodge Patents
When a multi-billion dollar product faces an import ban, the response is rarely to simply give up. Instead, companies often engage in what industry experts call a “technical pivot.” The recent battle between Apple and Masimo serves as a masterclass in this strategy.
To avoid a ban on the Apple Watch Series 9 and Ultra 2, Apple didn’t just remove the blood-oxygen feature. they redesigned the entire process. By moving the data processing from the watch itself to the paired iPhone, Apple successfully argued that the new version of the technology did not infringe on Masimo’s patents.
This trend suggests a future where health-tracking features become more modular. We may see more devices that act as simple data collectors, while the “intelligence” and analysis are handled by a separate hub or cloud service to navigate complex intellectual property landscapes.
MedTech vs. Big Tech: The Struggle for Health Data Control
The conflict between Apple and Masimo—now owned by Danaher—highlights a growing tension. Specialized medical technology companies possess deep, proprietary expertise in areas like pulse-oximetry, while Big Tech companies possess the scale to bring these features to millions of consumers.
The allegations in this case travel beyond simple patent disputes. Masimo accused Apple of poaching key engineers to gain access to proprietary technology for measuring blood oxygen levels. This points to a trend of “talent wars” where the acquisition of human capital is as strategic as the acquisition of patents.
As wearables evolve into medical-grade devices, we can expect more aggressive litigation from medtech firms seeking to protect their research and development investments from larger consumer electronics firms.
The ITC and the Power of the Import Ban
The utilize of the International Trade Commission (ITC) has become a powerful weapon in corporate warfare. Unlike standard lawsuits that seek monetary damages, the ITC can issue exclusion orders that stop products from even entering the country.
Apple experienced this firsthand in December 2023 when the ITC blocked imports of specific watch models. While Apple eventually cleared a major hurdle when the commission declined to review a ruling that their redesigned watches were non-infringing, the threat of an import ban remains a potent tool for smaller companies to force concessions from giants.
This trend indicates that the “exclusion order” is becoming a preferred first strike in patent disputes, as it creates immediate revenue loss and supply chain chaos, providing the plaintiff with significant leverage.
Future Outlook for Health Wearables
Looking ahead, the industry is likely to see a shift toward more transparent licensing agreements. Rather than spending six years in a “relentless legal campaign,” as Apple described it, companies may move toward preemptive partnerships to ensure health features reach the market faster.
the role of U.S. Customs and Border Protection will remain pivotal, as they are the final gatekeepers deciding if a “redesign” is sufficient to bypass an existing ban.
Frequently Asked Questions
What is pulse-oximetry technology?
It is the technology used to measure the oxygen saturation levels in a person’s blood, a key health metric integrated into many smartwatches.
Why were some Apple Watches banned in the US?
The ITC found that certain models, specifically the Series 9 and Ultra 2, infringed on patents held by Masimo related to blood-oxygen monitoring.
How did Apple resolve the import ban issue?
Apple redesigned the feature so that blood-oxygen data is displayed on the paired iPhone rather than directly on the watch face, which the ITC found did not infringe the patents.
Is the legal battle between Apple and Masimo over?
No. While the ITC closed one specific case, Masimo has separately sued U.S. Customs over the redesigned watches and is pursuing Apple in California federal court.
Join the Conversation
Do you think Big Tech companies should pay licensing fees to medtech firms for health sensors, or does this stifle innovation? Let us know in the comments below or subscribe to our newsletter for more industry insights.
